MEDITOR partner Sinocare presented iCan CGM innovation and clinical research at EASD 2026
MEDITOR partner Sinocare presented iCan CGM innovation and clinical research at EASD 2026
Sinocare, our partner and a manufacturer of solutions for people living with diabetes and related chronic conditions, is participating in the 62nd Annual Meeting of the European Association for the Study of Diabetes (EASD 2026) in Milan.
This year, the focus is on a comprehensive approach to managing chronic diseases and multisystem pathologies (CKM syndrome). Sinocare is showcasing its three-tiered ecosystem:
-
Home care: Safe AQ glucose monitoring systems and iCan CGM sensors.
-
Primary care: iCARE-1300 portable analyzers for rapid testing of over 100 parameters within 3–15 minutes.
-
Hospital segment: digital diabetes management systems with direct integration into Hospital Information Systems (HIS).
Evidence base for pediatrics
A highlight of the congress was the presentation of a scientific e-poster detailing the results of a US-based multicenter study (*Performance of the iCan CGM System in a pediatric sample*). The study confirmed the high accuracy and safety of the iCan CGM system for children and adolescents.
As Sinocare’s official partner in Ukraine, MEDITOR continues to introduce Ukrainian professionals and patients to state-of-the-art, evidence-based monitoring technologies and ensure their availability in the country.
